Abstract Presentation

Long-term Survival Benefits of Intrathecal Autologous Bone Marrow-derived Mesenchymal Stem Cells (Neuronata-R®: lenzumestrocel) Treatment in ALS: Propensity-score Matched Control, Surveillance Study